Joint MorphoSys and Incyte Conference Call
MorphoSys and Incyte will host a joint analyst and investor conference call and webcast scheduled for August 3, 2020 at 8:00 a.m. EDT / 2:00 p.m. CEST to discuss the FDA approval of Monjuvi®.
USA: 877 407 3042
International: +1 201 389 0864
Participant PIN: 13706810
Please dial in 10 minutes before the beginning of the conference.
Go to Webcast (audio only)